WDH-33598-77911
2 vaccinations
4 coded responses
17 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 339 / FL
- Registered
- 2021-04-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-08
Dose 1 — Janssen/Johnson & Johnson
-
2021-04-10
Registered in v-safe
-
2021-04-10
Survey response — days 1–6 daily, dose 1MedDRA: Injection site bruising, Respiratory tract congestion — Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessFree text: Bruising to injection site, congestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-11
- 2021-04-12
- 2021-04-22
- 2021-04-29
- 2021-05-06
- 2021-05-13
- 2021-05-20
- 2021-07-08
-
2021-10-07
Survey response — 6 months, dose 1MedDRA: Pregnancy — Feeling: GoodFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
-
2021-12-12
Dose 2 — Moderna
-
2022-01-03
Survey response — day 21, dose 2MedDRA: COVID-19 — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Positive covidMedDRA releases: 2024-11 · check-in free text available
-
2022-01-09
Survey response — day 28, dose 2MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: CovidMedDRA releases: 2024-11 · check-in free text available
-
2022-01-09
Report sent to call center — day 28, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-01-11
- 2022-01-18
- 2022-01-23
- 2022-03-13
- 2022-06-12
- 2022-12-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-08 | Janssen/Johnson & Johnson | |
| 2 | 2021-12-12 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-01-09 | Unsuccessful |
Free text
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): Bruising to injection site, congestion
Release 10 — 6 months, dose 1
Symptoms: Pregnancy
Release 10 — day 21, dose 2
Symptoms: Positive covid
Release 10 — day 28, dose 2
Symptoms: Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SRO | Injection site bruising | ✓ | ✓ | ✓ |
| SRO | Respiratory tract congestion | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release